PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Revenue, 2025
- $46M
- YoY, 2025
- −89.4%
- 5-year CAGR
- +10.0%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $46M | −89.4% |
| 2024 | $434M | +624.1% |
| 2023 | $60M | +125.7% |
| 2022 | $27M | −2.8% |
| 2021 | $27M | −4.4% |
| 2020 | $29M | +12,293.1% |
| 2019 | $231K | −99.3% |
| 2018 | $31M | +54.1% |
| 2017 | $20M | — |